亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Dapagliflozin in lupus nephritis: renal and hematologic outcomes from a randomized controlled trial

医学 蛋白尿 肾功能 内科学 狼疮性肾炎 随机对照试验 达帕格列嗪 肾脏疾病 泌尿科 安慰剂 尿检 泌尿系统 临床终点 肾病 胃肠病学 糖尿病 系统性红斑狼疮 肾 肌酐 临床试验 析因分析
作者
Nourelsabah Mohamed,Karem N Zayed,Muhammed Ahmed Elhadedy,Mohamed Hosney Badawi,Wael Ibrahim Mortada,Kareem A. Nabieh,Mohamed Abdel kader Sobh,Ayman Fathy Refaie
出处
期刊:Ndt Plus [Oxford University Press]
卷期号:19 (8): sfag231-sfag231 被引量:1
标识
DOI:10.1093/ckj/sfag231
摘要

Background: Lupus nephritis (LN) remains a major cause of chronic kidney disease (CKD) and end-stage renal disease despite advances in immunosuppressive therapy. Sodium-glucose cotransporter-2 (SGLT2) inhibitors confer renal protection in diabetic and nondiabetic CKD and have been associated with increases in hemoglobin levels, but their renal and hematologic effects in immune-mediated glomerulopathies such as LN are not well defined. Objective: To evaluate the renal and hematologic effects, efficacy, and safety of dapagliflozin as adjunctive therapy in patients with LN. Methods: = 41) for 12 months in addition to standard immunosuppressive therapy. The primary renal endpoint was percentage change in 24-h urinary protein excretion. Secondary renal outcomes included change in eGFR. Hematologic parameters assessed at baseline and 12 months included hemoglobin, erythropoietin, hepcidin, ferritin, and transferrin saturation. The primary analysis used analysis of covariance (ANCOVA) with adjustment for baseline values and clinically relevant covariates including age and background immunosuppressive therapy. Sensitivity analyses using log-transformed proteinuria were also performed. Additional analyses evaluated adjusted 12-month eGFR and eGFR slope. Results: At 12 months, dapagliflozin was associated with a numerical reduction in proteinuria compared with placebo; however, this difference did not reach statistical significance. Adjusted analyses using ANCOVA confirmed the absence of a significant treatment effect. No significant differences were observed in eGFR, eGFR slope, or hematologic parameters. Conclusion: In this randomized controlled trial, dapagliflozin was associated with a numerical reduction in proteinuria that did not reach statistical significance after adjustment for baseline characteristics and background immunosuppressive therapy. No significant effect on kidney function, eGFR slope, or hematologic parameters was observed. These findings suggest a possible signal that requires confirmation in larger, adequately powered, longer-duration studies.Clinical trials registration number: NCT05748925 (ClinicalTrials.gov). Registered 28 February 2023-Retrospectively registered (https://register.clinicaltrials.gov/prs/beta/studies/S000CWI200000138/recordSummary).

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
2秒前
pluto的应助被xin采纳,获得10
3秒前
NexusExplorer的应助被Coral369采纳,获得10
4秒前
研猫发布了新的文献求助10
9秒前
淡淡的志泽完成签到,获得积分10
9秒前
合适怜南完成签到,获得积分10
9秒前
11秒前
11秒前
渡增越发布了新的文献求助10
13秒前
13秒前
14秒前
14秒前
14秒前
15秒前
lysteph发布了新的文献求助10
16秒前
五十二赫兹完成签到 ,获得积分10
18秒前
寒冷的爆米花关注了科研通微信公众号
20秒前
April完成签到,获得积分10
21秒前
summer完成签到,获得积分10
23秒前
h11的应助被渡增越采纳,获得10
24秒前
25秒前
染8完成签到 ,获得积分10
25秒前
TBI发布了新的文献求助10
26秒前
VV2001完成签到,获得积分10
26秒前
28秒前
ddwdwdwdddw发布了新的文献求助10
30秒前
fuzhenwei完成签到 ,获得积分10
32秒前
34秒前
生动火龙果完成签到 ,获得积分10
35秒前
跳跃奇异果完成签到 ,获得积分10
35秒前
h11的应助被jiang采纳,获得10
37秒前
研猫发布了新的文献求助10
39秒前
fuzhenwei关注了科研通微信公众号
40秒前
平淡水之完成签到,获得积分10
42秒前
45秒前
ddwdwdwdddw完成签到,获得积分10
45秒前
Lucas的应助被科研通管家采纳,获得10
46秒前
ding的应助被科研通管家采纳,获得10
46秒前
Lucas的应助被科研通管家采纳,获得10
46秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8158533
求助须知:如何正确求助?哪些是违规求助? 9554333
关于积分的说明 21718908
捐赠科研通 7748056
什么是DOI,文献DOI怎么找? 3427015
关于科研通互助平台的介绍 2551841
邀请新用户注册赠送积分活动 2471242